Abstract:BackgroundBursopentin (BP5) is a multifunctional pentapeptide found in the chicken bursa of Fabricius. Recent study indicated that BP5 significantly stimulates expression of p53 protein in colon cancer HCT116 cells. However, the effects and underlying mechanisms of BP5 on HCT116 cell proliferation remain largely unclear.MethodsAnalyses of cell viability, cell cycle arrest as well as apoptosis were performed to study the actions of BP5 on HCT116 cells. Western blot analyse was assayed to measure the cell cycle-related and apoptosis-related proteins. Specific siRNAs targeting IRE1, ATF-6, and PERK were used for IRE1, ATF-6, and PERK knockdown, respectively. Cellular reactive oxygen species (ROS) were detected using a H2DCF-DA green fluorescence probe. Cytosolic free Ca2+ concentrations and mitochondrial membrane potential (ΔΨm) were measured using Fluo-3 AM and JC-1 stains, respectively.ResultsBP5 possessed strong inhibitory effects on the cell growth and induced apoptosis in HCT116 cells. Mechanistically, BP5 arrested the cell cycle at G1 phase by increasing p53 and p21 expression and decreasing cyclin E1-CDK2 complex expression. BP5 treatment dramatically activated the endoplasmic reticulum (ER) stress-mediated apoptotic pathway, as revealed by the significantly enhanced expression of unfolded protein response (UPR) sensors (IRE1α, ATF6, PERK) as well as downstream signaling molecules (XBP-1s, eIF2α, ATF4 and CHOP), and by the significantly altered the BP5-induced phenotypic changes in IRE1, ATF6, and PERK knockdown cells. Additionally, BP5-induced ER stress was accompanied by the accumulation of cytosolic free Ca2+ and intracellular ROS. Furthermore, BP5 treatment resulted in the increase of Bax expression, the decrease of Bcl-2 expression and the reduction of ΔΨm, subsequently causing a release of cytochrome c from the mitochondria into the cytoplasm and finally enhancing the activities of caspase-9 and -3. In addition, z-VAD-fmk, a pan-caspase inhibitor, markedly rescued BP5-induced cell viability reduction and reduced BP5-induced apoptosis.ConclusionsOur present results suggest that BP5 has an anticancer capacity to arrest cell cycle at G1 phase and to trigger ER stress/mitochondria-mediated caspase-dependent apoptosis in HCT116 cells. Therefore, our findings provide insight into further investigations of the anticancer activities of BP5.

Screening and identification of specific binding peptides to Bursopentin by phage display peptide library

[Antitumor Mechanism of Bursopentin (BP5)].

<i>Phellinus baumii</i> Polyphenol: A Potential Therapeutic Candidate against Lung Cancer Cells

Elucidation of the Anti-Colon Cancer Mechanism of Phellinus Baumii Polyphenol by an Integrative Approach of Network Pharmacology and Experimental Verification.

Inhibitory effect and mechanism of Bursal-derived pentapeptide-Ⅱ on tumor cell proliferation and its possible medanism

The Immunomodulatory Peptide Bursopentin (BP5) Enhances Proliferation and Induces Sigm Expression in DT40 Cells.

Screening and identification of hepatocellular carcinoma cell specific binding peptides using phage display peptide library

Bursopentin (BP5) induces G1 phase cell cycle arrest and endoplasmic reticulum stress/mitochondria-mediated caspase-dependent apoptosis in human colon cancer HCT116 cells

Discovery and Preclinical Evaluation of BPB-101: a Novel Triple Functional Bispecific Antibody Targeting GARP-TGF-β Complex/slc, Free TGF-β and PD-L1

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

Identification of a Novel Bcl-2 Inhibitor by Ligand-Based Screening and Investigation of Its Anti-cancer Effect on Human Breast Cancer Cells

Bursopentin (BP5) from Chicken Bursa of Fabricius Attenuates the Immune Function of Dendritic Cells

Screening a Phage Display Library for a Novel FGF8b-binding Peptide with Anti-Tumor Effect on Prostate Cancer

Gene Expression Profiling of Hybridoma Cells after Bursal-Derived Bioactive Factor BP5 Treatment

Screening and Identification of A Targeting Peptide to Hepatocarcinoma from A Phage Display Peptide Library

[Bio-Panning of Antagonistic Peptides Against HAb18G/CD147 and Their Function of Anti-Hepatoma Invasion].

Screening and Identification of TNF-α Binding Peptide and TNFR Blocking Peptide

Panning and Identification of a Colon Tumor Binding Peptide from a Phage Display Peptide Library

Screening and identification of the binding proteins with BPP-Ⅱ through T7 cDNA phage display

Screening and Optimization of Phage Display Cyclic Peptides Against the WDR5 WBM Site

The Biologically Functional Identification of a Novel TIM3-binding Peptide P26 in Vitro and in Vivo